Abstract
Experiments in CBA mice with transplanted CaO 1 ovarian carcinoma possessing common antigenic determinants with human ovarian carcinoma showed that specific immunotherapy with mucin containing CA 125 antigen inhibited tumor growth by 60% and prolonged antimal lifespan by 40–60% in comparison with the control. The correlation coefficient between the tumor size and antibody titer after injection of mucin was −0.4 for IgM and −0.6 for IgG. Titration of IgG may be used for monitoring of the efficiency of specific immunotherapy.
Similar content being viewed by others
References
B. S. Amandzholov, Yu. S. Lebedin, S. V. Chukanov, et al.,Byull. Eksp. Biol. Med.,127, No. 2, 227–229 (1999).
J. W. Hodge,Cancer Immunol. Immunother.,43, 127–134 (1996).
D. L. Morton and A. Barth,CA Cancer J. Clin.,46, 225–244 (1996).
Author information
Authors and Affiliations
Additional information
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 129, No. 4, pp. 456–458, April, 2000
Rights and permissions
About this article
Cite this article
Amandzholov, B.S., Sitdikova, S.M., Lebedin, Y.S. et al. Antitumor activity of specific immunotherapy with mucin containing CA 125 antigen in mice with CaO 1 ovarian carcinoma. Bull Exp Biol Med 129, 383–385 (2000). https://doi.org/10.1007/BF02439278
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02439278